Measuring Cytotoxicity by Bioluminescence Imaging Outperforms the Standard Chromium-51 Release Assay

The chromium-release assay developed in 1968 is still the most commonly used method to measure cytotoxicity by T cells and by natural killer cells. Target cells are loaded in vitro with radioactive chromium and lysis is determined by measuring chromium in the supernatant released by dying cells. Since then, alternative methods have been developed using different markers of target cell viability that do not involve radioactivity. Here, we compared and contrasted a bioluminescence (BLI)-based cytotoxicity assay to the standard radioactive chromium-release assay using an identical set of effector cells and tumor target cells. For this, we stably transduced several human and murine tumor cell lines to express luciferase. When co-cultured with cytotoxic effector cells, highly reproducible decreases in BLI were seen in an effector to target cell dose-dependent manner. When compared to results obtained from the chromium release assay, the performance of the BLI-based assay was superior, because of its robustness, increased signal-to-noise ratio, and faster kinetics. The reduced/delayed detection of cytotoxicity by the chromium release method was attributable to the association of chromium with structural components of the cell, which are released quickly by detergent solubilization but not by hypotonic lysis. We conclude that the (BLI)-based measurement of cytotoxicity offers a superior non-radioactive alternative to the chromium-release assay that is more robust and quicker to perform.

[1]  C. Contag,et al.  Enhanced Killing of Primary Ovarian Cancer by Retargeting Autologous Cytokine-Induced Killer Cells with Bispecific Antibodies: A Preclinical Study , 2006, Clinical Cancer Research.

[2]  P. Mannucci,et al.  Phenotype‐genotype characterization of 10 families with severe a subunit factor XIII deficiency , 2004, Human mutation.

[3]  S. Gambhir,et al.  Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. , 2008, Clinical immunology.

[4]  I. Pócsi,et al.  Interference of chromium with biological systems in yeasts and fungi: a review , 2010, Journal of basic microbiology.

[5]  S. Das,et al.  Biosorption of hexavalent chromium by Termitomyces clypeatus biomass: kinetics and transmission electron microscopic study. , 2009, Journal of hazardous materials.

[6]  G. Shearer,et al.  Induction and Measurement of Cytotoxic T Lymphocyte Activity , 2006, Current protocols in immunology.

[7]  I. Goldman,et al.  Chromate transport in human leukocytes. , 1970, The Journal of clinical investigation.

[8]  K. Anderson,et al.  Compartment-Specific Bioluminescence Imaging platform for the high-throughput evaluation of antitumor immune function. , 2012, Blood.

[9]  B. Michalke,et al.  Intracellular chromium localization and cell physiological response in the unicellular alga Micrasterias , 2012, Aquatic toxicology.

[10]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.

[11]  C. Contag,et al.  Advances in in vivo bioluminescence imaging of gene expression. , 2002, Annual review of biomedical engineering.

[12]  K. Pantel,et al.  A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells. , 1995, Journal of immunological methods.

[13]  D. McMillin,et al.  Accessory Cells of the Microenvironment Protect Multiple Myeloma from T-Cell Cytotoxicity through Cell Adhesion-Mediated Immune Resistance , 2013, Clinical Cancer Research.

[14]  C. Fathman,et al.  CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation , 2003, Nature Medicine.

[15]  R. Negrin,et al.  Silencing Human NKG2D, DAP10, and DAP12 Reduces Cytotoxicity of Activated CD8+ T Cells and NK Cells1 , 2005, The Journal of Immunology.

[16]  Robert S Negrin,et al.  Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells. , 2004, Blood.

[17]  Y. Nakagawa,et al.  One-step simple assay to determine antigen-specific cytotoxic activities by single-color flow cytometry. , 2011, Biomedical research.

[18]  K. Anderson,et al.  Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anti-cancer drug activity , 2010, Nature Medicine.

[19]  A. Mackensen,et al.  The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity. , 2003, Methods.

[20]  L. Bruins,et al.  Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing. , 2005, Journal of immunological methods.

[21]  E. Bertram,et al.  A novel cytotoxicity assay to evaluate antigen-specific CTL responses using a colorimetric substrate for Granzyme B. , 2003, Journal of immunological methods.

[22]  S. Salvioli,et al.  The use of non-radioactive chromium as an alternative to 51Cr in NK assay. , 1995, Journal of immunological methods.